Meredith Fisher - Profile and Investment Details

Investor Profile

Meredith Fisher is a Venture Capital, Investor based in Cambridge, Massachusetts, United States with a diverse investment portfolio that includes companies such as CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance, ZielBio, Mediar Therapeutics, TargAnox, Editas Medicine, Lysosomal Therapeutics, Enlight Biosciences/ PureTech Ventures, Pykus Therapeutics, Annovation BioPharma, Abcuro, Nocion Therapeutics, Bracebridge Capital, LLC- Private Office, Translate Bio, Sebacia, ROME Therapeutics, Daktari Diagnostics, SwanBio Therapeutics, Raze Therapeutics, lifeIMAGE, Keros Therapeutics, Spero Therapeutics, Alizé Pharma, Akouos, Syntimmune, Triplet TherapeuticsAffinia Therapeutics, QPID Health, . Over time, Meredith Fisher has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Meredith Fisher is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Drug Discovery, Wellness, Women Founded, Life Science, Engineering, Biotechnology, Research, Health Diagnostics, Medical, B2B, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Meredith Fisher, as their portfolio suggests a familiarity and interest in this area.

Understanding Meredith Fisher’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.